Displaying drugs 2226 - 2250 of 2780 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Selinexor | 443.313 C17H11F6N7O | Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. Selinexor is also indicated... | Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Nuclear Export Inhibitors / OATP1B3 inhibitors | |
Delafloxacin | 440.76 C18H12ClF3N4O4 | A fluoroquinolone antibiotic used to treat skin and skin structure infections. | Fluoroquinolones | |
Lemborexant | 410.425 C22H20F2N4O2 | A dual orexin antagonist indicated for the treatment of sleep-onset and/or sleep maintenance insomnia. | Orexin Receptor Antagonists | |
Duvelisib | 416.87 C22H17ClN6O | An inhibitor of phosphatidylinositol 3-kinase delta and gamma used to treat relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | |
Dacomitinib | 469.939 C24H25ClFN5O2 | A medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors | |
Binimetinib | 441.233 C17H15BrF2N4O3 | A medication used to treat metastatic melanoma with specific mutations. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors | |
Glasdegib | 374.448 C21H22N6O | A sonic hedgehog receptor inhibitor used to treat newly diagnosed acute myeloid leukemia in patients over 75 years who cannot receive intense chemotherapy. | Hedgehog pathway inhibitors | |
Elagolix | 631.6 C32H30F5N3O5 | A gonadotropin releasing hormone receptor antagonist used to treat moderate to severe pain in endometriosis. | Anti-Gonadotropin-Releasing Hormones | |
Entrectinib | 560.65 C31H34F2N6O2 | Entrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment... | Protein Kinase Inhibitors | |
Benznidazole | 260.253 C12H12N4O3 | A trypanocidal agent used to treat Chagas disease. | Nitroimidazole Derivatives | |
Diacerein | 368.297 C19H12O8 | An slow-onset anthraquinone IL-1 inhibitor used in the treatment of degenerative joint diseases like osteoarthritis. | Anti-Inflammatory Agents | |
Avatrombopag | 649.65 C29H34Cl2N6O3S2 | A thrombopoietin receptor agonist used pre-operatively to treat thrombocytopenia in patients with chronic liver disease and in patients with chronic refractory thrombocytopenia. | Receptors, Thrombopoietin, agonists | |
Abemaciclib | 506.606 C27H32F2N8 | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors | |
Nirogacestat | 489.656 C27H41F2N5O | A gamma-secretase inhibitor used to treat desmoid tumors | Amyloid Precursor Protein Secretases, antagonists & inhibitors / Gamma Secretase Inhibitors and Modulators | |
Fostamatinib | 580.4595 C23H26FN6O9P | A spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia after attempting one other treatment. | Amines / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Experimental Unapproved Treatments for COVID-19 / Hemostatics / Kinase Inhibitor / Oxazines / Phosphodiesterase 5 Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A9 Substrates / Vasodilating Agents | |
Alpelisib | 441.47 C19H22F3N5O2S | Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor... | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | |
Ponesimod | 460.97 C23H25ClN2O4S | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. | Selective Immunosuppressants | |
Tecovirimat | 376.335 C19H15F3N2O3 | An antiviral medication used to treat smallpox, monkeypox, and cowpox. | Anti-Infective Agents | |
Voxilaprevir | 868.94 C40H52F4N6O9S | A nonstructural protein 3 and 4a protease inhibitor used to treat Hepatitis C infections. | Antivirals for treatment of HCV infections | |
Sarecycline | 487.509 C24H29N3O8 | A tetracycline antibiotic used to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris. | Anti-Bacterial Agents / Dermatologicals / Tetracyclines | |
Letermovir | 572.561 C29H28F4N4O4 | An antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease. | Antiviral Agents / Cytomegalovirus DNA Terminase Complex Inhibitor / Poly(ADP-ribose) Polymerase Inhibitors | |
Gadolinium | 157.25 Gd | Gadolinium is under investigation in Hypertension, ACUTE KIDNEY INJURY, and Chronic Kidney Disease. Gadolinium has been investigated for the basic science of CAD, Multiple Sclerosis, and Coronary Artery Disease. | Anti-Inflammatory Agents / Contrast Media / Lanthanoid Series Elements | |
Telotristat ethyl | 574.99 C27H26ClF3N6O3 | A tryptophan hydroxylase inhibitor that is used to treat carcinoid syndrome diarrhea. | Tryptophan Hydroxylase Inhibitor | |
Mannitol busulfan | 338.34 C8H18O10S2 | Mm has been used in trials studying the treatment of Cocaine Dependence and Diabetes Mellitus, Type 2. | Agents causing hyperkalemia | |
Vaborbactam | 297.13 C12H16BNO5S | A beta lactamase inhibitor used to treat complicated urinary tract infections. | beta-Lactamase Inhibitors |
Displaying drugs 2226 - 2250 of 2780 in total